CGTLive’s Weekly Rewind – July 29, 2022

Welcome to CGTLive’s Weekly Rewind! We’ve compiled 5 highlights from this week’s coverage of advances in gene and cell therapies, including FDA actions, notable research, and interviews with experts across the field.

1. Editas' Gene Therapy Trial for Sickle Cell Initiates After Hold Lifted

The company announced successful neutrophil and platelet engraftment for the first patient dosed.

2. Nilanjan Ghosh, MD, PhD, on New Avenues of CAR T Research in Lymphoma

The chief of the lymphoma division and oncologist at Levine Cancer Institute discussed new CAR T-cell therapies being investigated for hematologic malignancies.

3. Gamma-Delta T-cell Therapy Shows Durable Complete Responses in Acute Myeloid Leukemia

All 3 patients remained progression-free at more than 1 year post-treatment.

4. Susan Ruediger on Partnering to Develop CMT Gene Therapies

Susan Ruediger, founder and chief mission officer, CMT Research Foundation, discussed a new partnership with Nationwide Children’s Hospital.

5. Nanoscope Gene Therapy Continues Progress in Stargardt Disease

Data is expected in the first quarter of 2023 for both Stargardt disease and retinitis pigmentosa.